Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer

NEXT STORY
Numi Health Launches Mobile Intravenous Nutrient Therapy
PREV STORY
Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)

author_avatar
NASDAQ Market News

Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™

author_avatar
NASDAQ Market News

Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development, and Key Geographies : Industry Trends and Global Forecasts, 2020-2050

author_avatar
NASDAQ Market News